Minimally Invasive Healthcare (00853) fell nearly 4% at the end of the session. As of press release, it was down 3.92% to HK$6.12, with a turnover of HK$49.6016 million.
The Zhitong Finance App learned that Minimally Invasive Healthcare (00853) fell nearly 4% at the end of the session. As of press release, it was down 3.92% to HK$6.12, with a turnover of HK$496.16 million.
According to the news, Minimally Invasive Healthcare recently announced that the $448 million convertible bond will expire in June. The company has entered into convertible financing agreements with lenders such as Gao Lin Capital to obtain a total of 150 million US dollars in convertible term loan financing, and is expected to receive more than 300 million US dollars in credit support from financial institutions. Debt concerns have been properly handled for the time being.
Nomura pointed out that the exercise price of US$150 million was HK$7.46, and the company must meet its performance targets. Otherwise, it will be necessary to repay the $50 million loan from High House Capital in advance. The bank believes that the situation may improve in the short term, but it will still be difficult in the long run. As a result, the target price for minimally invasive medicine was lowered from HK$7.19 to HK$6.71, giving it a “neutral” rating.